CBD Use and Liver Injury: Practical Considerations for Primary Care - Frankly Speaking Ep 339

<p>Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-339'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-339</a></p> <p>Overview: In this episode, we dive into a recent systematic review and meta-analysis confirming the association between cannabidiol (CBD) use and hepatotoxicity. Gain a deeper understanding of clinical applications and the delicate balance of risks and benefits when discussing CBD use with your patients.</p> <p>Episode resource links:</p> <ul><li>Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023 Mar 13. doi: 10.1111/joim.13627. Epub ahead of print. PMID: 36912195.</li> <li><a href='https://store.samhsa.gov/sites/default/files/pep22-06-04-003.pdf'>https://store.samhsa.gov/sites/default/files/pep22-06-04-003.pdf</a></li> </ul> <p>Guest: Jillian Joseph, MPAS, PA-C   Music Credit: Richard Onorato</p>